NZ224131A - Purine-substituted ribofuranuronic acid derivatives and medicaments - Google Patents

Purine-substituted ribofuranuronic acid derivatives and medicaments

Info

Publication number
NZ224131A
NZ224131A NZ224131A NZ22413188A NZ224131A NZ 224131 A NZ224131 A NZ 224131A NZ 224131 A NZ224131 A NZ 224131A NZ 22413188 A NZ22413188 A NZ 22413188A NZ 224131 A NZ224131 A NZ 224131A
Authority
NZ
New Zealand
Prior art keywords
alkyl
substituted
hydroxyl
group
vherein
Prior art date
Application number
NZ224131A
Other languages
English (en)
Inventor
Fulvio Gadient
Arnold Vogel
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of NZ224131A publication Critical patent/NZ224131A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NZ224131A 1987-04-06 1988-04-06 Purine-substituted ribofuranuronic acid derivatives and medicaments NZ224131A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3711561 1987-04-06
DE3711563 1987-04-06
DE3711564 1987-04-06
DE3711562 1987-04-06

Publications (1)

Publication Number Publication Date
NZ224131A true NZ224131A (en) 1991-12-23

Family

ID=27433888

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ224131A NZ224131A (en) 1987-04-06 1988-04-06 Purine-substituted ribofuranuronic acid derivatives and medicaments

Country Status (22)

Country Link
JP (1) JPS63258892A (fr)
KR (1) KR880012629A (fr)
AT (1) AT393507B (fr)
AU (1) AU609109B2 (fr)
BE (1) BE1002151A5 (fr)
CA (1) CA1326017C (fr)
CH (1) CH676121A5 (fr)
DK (1) DK183488A (fr)
ES (1) ES2007177A6 (fr)
FI (1) FI87463C (fr)
FR (1) FR2613367A1 (fr)
GB (1) GB2203149B (fr)
HU (1) HU201955B (fr)
IL (1) IL85969A (fr)
IT (1) IT1219892B (fr)
LU (1) LU87181A1 (fr)
MY (1) MY102323A (fr)
NL (1) NL8800862A (fr)
NZ (1) NZ224131A (fr)
PH (1) PH25424A (fr)
PT (1) PT87153B (fr)
SE (1) SE8801236A0 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4755594A (en) * 1986-01-31 1988-07-05 Warner-Lambert Company N6 -substituted adenosines
US4954504A (en) * 1986-11-14 1990-09-04 Ciba-Geigy Corporation N9 -cyclopentyl-substituted adenine derivatives having adenosine-2 receptor stimulating activity
US5063233A (en) * 1986-11-14 1991-11-05 Ciba-Geigy Corporation N9 -cyclopentyl-substituted adenine derivatives useful as adenosine receptor agonists
NL8702926A (nl) * 1986-12-15 1988-07-01 Sandoz Ag Nieuwe furanuronzuurderivaten en werkwijzen voor het bereiden en toepassen van deze derivaten.
PT86660B (pt) * 1987-02-04 1992-02-28 Ciba Geigy Ag Processo para a preparacao de derivados de adenosina-5'-carboxamida
US4968697A (en) * 1987-02-04 1990-11-06 Ciba-Geigy Corporation 2-substituted adenosine 5'-carboxamides as antihypertensive agents
USRE36494E (en) * 1990-02-20 2000-01-11 Discovery Therapeutics, Inc. 2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents
US5140015A (en) * 1990-02-20 1992-08-18 Whitby Research, Inc. 2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents
IT1254915B (it) * 1992-04-24 1995-10-11 Gloria Cristalli Derivati di adenosina ad attivita' a2 agonista
GB9301000D0 (en) * 1993-01-20 1993-03-10 Glaxo Group Ltd Chemical compounds
TW528755B (en) 1996-12-24 2003-04-21 Glaxo Group Ltd 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
YU44900A (sh) 1998-01-31 2003-01-31 Glaxo Group Limited Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola
ID29609A (id) 1998-06-23 2001-09-06 Glaxo Group Ltd Turunan 2-(purin-9-il)-tetrahidrofuran-3,4-diol
WO2000063703A1 (fr) 1999-04-16 2000-10-26 Schering Corporation Utilisation de composes a base d'azetodinone
US20050033044A1 (en) 2003-05-19 2005-02-10 Bristol-Myers Squibb Pharma Company Methods for preparing 2-alkynyladenosine derivatives
PE20060272A1 (es) 2004-05-24 2006-05-22 Glaxo Group Ltd (2r,3r,4s,5r,2'r,3'r,4's,5's)-2,2'-{trans-1,4-ciclohexanodiilbis-[imino(2-{[2-(1-metil-1h-imidazol-4-il)etil]amino}-9h-purin-6,9-diil)]}bis[5-(2-etil-2h-tetrazol-5-il)tetrahidro-3,4-furanodiol] como agonista a2a
JP5011112B2 (ja) * 2004-09-20 2012-08-29 イノテック ファーマシューティカルズ コーポレイション プリン誘導体を含有する炎症性疾患の治療用医薬
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH606084A5 (en) * 1975-02-18 1978-10-13 Hoffmann La Roche (Di) nitrates of adenosine -5'-carboxylic acid derivs
US4167565A (en) * 1976-11-08 1979-09-11 Abbott Laboratories Adenosine-5'-carboxamides and method of use
DE3406533A1 (de) * 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten
NL8702926A (nl) * 1986-12-15 1988-07-01 Sandoz Ag Nieuwe furanuronzuurderivaten en werkwijzen voor het bereiden en toepassen van deze derivaten.
PT86660B (pt) * 1987-02-04 1992-02-28 Ciba Geigy Ag Processo para a preparacao de derivados de adenosina-5'-carboxamida

Also Published As

Publication number Publication date
PH25424A (fr) 1991-07-01
DK183488A (da) 1988-10-07
IT1219892B (it) 1990-05-24
SE8801236L (sv) 1988-10-17
GB8807750D0 (en) 1988-05-05
FI87463C (fi) 1993-01-11
FI881571A (fi) 1988-10-07
SE8801236D0 (sv) 1988-04-05
BE1002151A5 (fr) 1990-08-07
IT8847794A0 (it) 1988-03-30
ATA87388A (de) 1991-04-15
PT87153B (pt) 1992-07-31
IL85969A0 (en) 1988-09-30
PT87153A (pt) 1988-05-01
GB2203149B (en) 1991-02-13
FR2613367A1 (fr) 1988-10-07
AU609109B2 (en) 1991-04-26
CA1326017C (fr) 1994-01-11
AT393507B (de) 1991-11-11
CH676121A5 (fr) 1990-12-14
KR880012629A (ko) 1988-11-28
HUT48902A (en) 1989-07-28
IL85969A (en) 1992-03-29
SE8801236A0 (sv) 1988-10-17
DK183488D0 (da) 1988-04-05
FI881571A0 (fi) 1988-04-05
MY102323A (en) 1992-05-28
ES2007177A6 (es) 1989-06-01
LU87181A1 (fr) 1988-11-17
GB2203149A (en) 1988-10-12
FI87463B (fi) 1992-09-30
AU1415188A (en) 1988-10-06
JPS63258892A (ja) 1988-10-26
NL8800862A (nl) 1988-11-01
HU201955B (en) 1991-01-28

Similar Documents

Publication Publication Date Title
NZ224131A (en) Purine-substituted ribofuranuronic acid derivatives and medicaments
CA1287349C (fr) Analogues de la rebeccamycine
US5219840A (en) Antihypertensive 9-(2,N6 -disubstituted adenyl) ribofuranuronic acid derivatives
US5547941A (en) Cyclic dinucleoside diphosphorothioates, related compounds and pharmaceutical compositions
US5384310A (en) 2'-fluoro-2-haloarabinoadinosines and their pharmaceutical compositions
SK9293A3 (en) New phospolipid-derivatives of nucleosides, their preparation and their use as antiviral drugs
JP2021523191A (ja) （チオ）ニコチンアミドリボフラノシド塩および組成物、製造方法、およびそれらの使用
AU601247B2 (en) New furanuronic acid derivatives, process for their production and their use
US4067867A (en) Process for preparing pyrazine precursor of methotrexate or an N-substituted derivative thereof and/or a di(lower)alkyl ester thereof
CH642054A5 (de) Alpha-acetylenische derivate von alpha-aminosaeuren und ein verfahren zu deren herstellung.
US5534503A (en) 2'-O, N6 -disubstituted and 2'-O, N6, 2-trisubstituted adenosines and their medicinal uses
US4719295A (en) Compound 2-iodo-2'-deoxyadenosine
AU672994B2 (en) Liponucleotides of seco-nucleosides, their preparation and their use as anti-viral drugs
NO880606L (no) Nukleotidanaloger og fremgangsmaate for deres fremstilling.
US20190241606A1 (en) Process for preparation of cangrelor tetrasodium and intermediate therefor
WO2006122207A1 (fr) 6-hydrazinopurine 2'-methyl ribonucleosides et nucleotides pour le traitement de hcv
PL155212B1 (en) Method of obtaining novel derivatives or ribofuranuronic acid
Suami et al. Synthesis and antitumor activity of water-soluble (2-chloroethyl) nitrosoureas
HUT60504A (en) Process for producing new adenosine derivatives and pharmaceutical compositions comprising such compounds
EP0601520A1 (fr) Derivés de trifluorothymidine, procédé pour leur production et agent anticancer qui les contient
JPH06116267A (ja) ６’−ｃ−アルキルもしくはアルキニルネプラノシンａ、その製造方法およびその用途
JPH02262588A (ja) 新規フォスフォン酸誘導体
PL154766B1 (pl) Sposób wytwarzania nowych pochodnych kwasu furanuronowego
JPH04230383A (ja) ２−クロロ−１，７−ジヒドロプリン−６−オンの製造方法及びその精製方法
CA2069714A1 (fr) Preparation de derives de 6-o-acylelsamicine a